| Paul H Mccabe, MD | |
|
1250 S Cedar Crest Blvd Ste 405, Allentown, PA 18103-6224 | |
| (610) 402-8420 | |
| (610) 402-1689 |
| Full Name | Paul H Mccabe |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 37 Years |
| Location | 1250 S Cedar Crest Blvd Ste 405, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114975299 | NPI | - | NPPES |
| 00128787 | Medicaid | PA | |
| 0012807870001 | Medicaid | PA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Lehigh Valley Hospital - Pocono | East stroudsburg, PA | Hospital |
| Lehigh Valley Hospital - Hazleton | Hazleton, PA | Hospital |
| Schuylkill Medical Center - South Jackson Street | Pottsville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Schuylkill Health System Medical Group, Inc. | 0840285532 | 87 |
| Lehigh Valley Physician Group | 3072425123 | 1763 |
| Hazleton Professional Services | 8022110402 | 129 |
News Archive
Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announced today the grant of US Patent 7,807,138 entitled "Biomarkers of Metabolic Responses to Hepatic Drugs". The USPTO awarded the patent to Metabolon on October 5, 2010. This is the 13th patent issued to Metabolon and the second in its portfolio of biomarker patents.
Memphis Mayor, A.C. Wharton stands up for the outstanding Memphis-based National Bipolar Foundation; a press conference is to be hosted by University of Tennessee Health & Science Center on November 17th at 2pm at the Student Center at 800 Madison in Room 305.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today jointly announced that Seattle Genetics and Millennium have entered into an agreement to globally develop and commercialize brentuximab vedotin (SGN-35).
In a paper recently uploaded to the preprint server bioRxiv* by Kulkarni et al. (August 3, 2021), the potential of vaccinia virus-based vaccines expressing the full-length SARS-CoV-2 spike protein is examined in mice and Syrian hamsters. The findings report that the vaccine generates high titers of neutralizing antibodies with good activity towards SARS-CoV-2 variants of concern.
People with a rare dementia that initially attacks the language center of the brain recruit other areas of the brain to decipher sentences, according to new research led by a University of Arizona cognitive scientist.
› Verified 2 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announced today the grant of US Patent 7,807,138 entitled "Biomarkers of Metabolic Responses to Hepatic Drugs". The USPTO awarded the patent to Metabolon on October 5, 2010. This is the 13th patent issued to Metabolon and the second in its portfolio of biomarker patents.
Memphis Mayor, A.C. Wharton stands up for the outstanding Memphis-based National Bipolar Foundation; a press conference is to be hosted by University of Tennessee Health & Science Center on November 17th at 2pm at the Student Center at 800 Madison in Room 305.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today jointly announced that Seattle Genetics and Millennium have entered into an agreement to globally develop and commercialize brentuximab vedotin (SGN-35).
In a paper recently uploaded to the preprint server bioRxiv* by Kulkarni et al. (August 3, 2021), the potential of vaccinia virus-based vaccines expressing the full-length SARS-CoV-2 spike protein is examined in mice and Syrian hamsters. The findings report that the vaccine generates high titers of neutralizing antibodies with good activity towards SARS-CoV-2 variants of concern.
People with a rare dementia that initially attacks the language center of the brain recruit other areas of the brain to decipher sentences, according to new research led by a University of Arizona cognitive scientist.
› Verified 2 days ago
| Entity Name | Schuylkill Health System Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588603567 PECOS PAC ID: 0840285532 Enrollment ID: O20040420001197 |
News Archive
Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announced today the grant of US Patent 7,807,138 entitled "Biomarkers of Metabolic Responses to Hepatic Drugs". The USPTO awarded the patent to Metabolon on October 5, 2010. This is the 13th patent issued to Metabolon and the second in its portfolio of biomarker patents.
Memphis Mayor, A.C. Wharton stands up for the outstanding Memphis-based National Bipolar Foundation; a press conference is to be hosted by University of Tennessee Health & Science Center on November 17th at 2pm at the Student Center at 800 Madison in Room 305.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today jointly announced that Seattle Genetics and Millennium have entered into an agreement to globally develop and commercialize brentuximab vedotin (SGN-35).
In a paper recently uploaded to the preprint server bioRxiv* by Kulkarni et al. (August 3, 2021), the potential of vaccinia virus-based vaccines expressing the full-length SARS-CoV-2 spike protein is examined in mice and Syrian hamsters. The findings report that the vaccine generates high titers of neutralizing antibodies with good activity towards SARS-CoV-2 variants of concern.
People with a rare dementia that initially attacks the language center of the brain recruit other areas of the brain to decipher sentences, according to new research led by a University of Arizona cognitive scientist.
› Verified 2 days ago
| Entity Name | Hazleton Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952464638 PECOS PAC ID: 8022110402 Enrollment ID: O20070305000195 |
News Archive
Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announced today the grant of US Patent 7,807,138 entitled "Biomarkers of Metabolic Responses to Hepatic Drugs". The USPTO awarded the patent to Metabolon on October 5, 2010. This is the 13th patent issued to Metabolon and the second in its portfolio of biomarker patents.
Memphis Mayor, A.C. Wharton stands up for the outstanding Memphis-based National Bipolar Foundation; a press conference is to be hosted by University of Tennessee Health & Science Center on November 17th at 2pm at the Student Center at 800 Madison in Room 305.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today jointly announced that Seattle Genetics and Millennium have entered into an agreement to globally develop and commercialize brentuximab vedotin (SGN-35).
In a paper recently uploaded to the preprint server bioRxiv* by Kulkarni et al. (August 3, 2021), the potential of vaccinia virus-based vaccines expressing the full-length SARS-CoV-2 spike protein is examined in mice and Syrian hamsters. The findings report that the vaccine generates high titers of neutralizing antibodies with good activity towards SARS-CoV-2 variants of concern.
People with a rare dementia that initially attacks the language center of the brain recruit other areas of the brain to decipher sentences, according to new research led by a University of Arizona cognitive scientist.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul H Mccabe, MD Po Box 783311, Philadelphia, PA 19178-3311 Ph: (484) 884-4500 | Paul H Mccabe, MD 1250 S Cedar Crest Blvd Ste 405, Allentown, PA 18103-6224 Ph: (610) 402-8420 |
News Archive
Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announced today the grant of US Patent 7,807,138 entitled "Biomarkers of Metabolic Responses to Hepatic Drugs". The USPTO awarded the patent to Metabolon on October 5, 2010. This is the 13th patent issued to Metabolon and the second in its portfolio of biomarker patents.
Memphis Mayor, A.C. Wharton stands up for the outstanding Memphis-based National Bipolar Foundation; a press conference is to be hosted by University of Tennessee Health & Science Center on November 17th at 2pm at the Student Center at 800 Madison in Room 305.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today jointly announced that Seattle Genetics and Millennium have entered into an agreement to globally develop and commercialize brentuximab vedotin (SGN-35).
In a paper recently uploaded to the preprint server bioRxiv* by Kulkarni et al. (August 3, 2021), the potential of vaccinia virus-based vaccines expressing the full-length SARS-CoV-2 spike protein is examined in mice and Syrian hamsters. The findings report that the vaccine generates high titers of neutralizing antibodies with good activity towards SARS-CoV-2 variants of concern.
People with a rare dementia that initially attacks the language center of the brain recruit other areas of the brain to decipher sentences, according to new research led by a University of Arizona cognitive scientist.
› Verified 2 days ago
Adam B. Edwards, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 405, Allentown, PA 18103 Phone: 610-402-8420 Fax: 610-402-1689 | |
Soraya E Jimenez, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 405, Allentown, PA 18103 Phone: 610-402-8420 Fax: 610-402-1689 | |
Dr. Alissa Eileen Romano, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 4-5, Allentown, PA 18103 Phone: 610-402-8420 Fax: 610-402-1689 | |
Irene Chu, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-5100 | |
Brian Sacks, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 484-862-3200 | |
Jay Varrato, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1210 S Cedar Crest Blvd, Suite 1800, Allentown, PA 18103 Phone: 610-402-8420 Fax: 610-402-1689 | |
Ron Mahlab, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 210 N 6th St, Allentown, PA 18102 Phone: 610-432-4356 Fax: 484-221-9130 |